These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 4242640)

  • 41. Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
    Palatini P
    Mol Pharmacol; 1977 Mar; 13(2):216-23. PubMed ID: 192990
    [No Abstract]   [Full Text] [Related]  

  • 42. Action of amiodarone on guinea pig heart sodium and potassium activated adenosine triphosphatase. Comparison with ouabain.
    Broekhuysen J; Clinet M; Delisee C
    Biochem Pharmacol; 1972 Nov; 21(22):2951-60. PubMed ID: 4265331
    [No Abstract]   [Full Text] [Related]  

  • 43. The complexes of ouabain with sodium- and potassium-activated adenosine triphosphatase formed with various ligands: relationship to the complex formed in the beating heart.
    Akera T; Ku D; Tobin T; Brody TM
    Mol Pharmacol; 1976 Jan; 12(1):101-14. PubMed ID: 130537
    [No Abstract]   [Full Text] [Related]  

  • 44. A SODIUM AND POTASSIUM-STIMULATED ADENOSINE TRIPHOSPHATASE FROM CARDIAC TISSUES. 3. THE PROPERTIES OF AN ENDOGENOUS INHIBITORY FACTOR.
    SCHWARTZ A; LASETER AH
    Biochem Pharmacol; 1964 Jun; 13():921-34. PubMed ID: 14186840
    [No Abstract]   [Full Text] [Related]  

  • 45. Interaction of ouabain and K+ in vivo with respect to renal adenosine triphosphatase activity and Na+ reabsorption.
    Nelson JA; Nechay BR
    J Pharmacol Exp Ther; 1971 Mar; 176(3):558-62. PubMed ID: 4255766
    [No Abstract]   [Full Text] [Related]  

  • 46. A cycle for ouabain inhibition of sodium- and potassium-dependent adenosine triphosphatase.
    Sen AK; Tobin T
    J Biol Chem; 1969 Dec; 244(24):6596-604. PubMed ID: 4243425
    [No Abstract]   [Full Text] [Related]  

  • 47. Factors and agents that influence cardiac glycoside-Na+, K+-ATPase interaction.
    Akera T; Brody TM; So RH; Tobin T; Baskin SI
    Ann N Y Acad Sci; 1974; 242(0):617-34. PubMed ID: 4279610
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of antibodies in the study of the mechanism of action of digitalis.
    Smith TW
    Ann N Y Acad Sci; 1974; 242(0):731-65. PubMed ID: 4279618
    [No Abstract]   [Full Text] [Related]  

  • 49. The nature of the transport adenosine triphosphatase-digitalis complex. VII. Characteristics of ouabagenin-Na+,K+-adenosine triphosphatase interaction.
    Wallick ET; Dowd F; Allen JC; Schwartz A
    J Pharmacol Exp Ther; 1974 May; 189(2):434-44. PubMed ID: 4275234
    [No Abstract]   [Full Text] [Related]  

  • 50. Ouabain-induced inhibition of cardiac (Na+ plus K+)-ATPase and the positive inotropic response.
    Schwartz A
    Ann N Y Acad Sci; 1974; 242(0):683. PubMed ID: 4279615
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition by quercetin of magnesium-, sodium- and potassium-activated adenosine triphosphatase.
    Bruni A; Carpenedo F; Santi R
    Br J Pharmacol; 1968 Nov; 34(3):673P-674P. PubMed ID: 4235807
    [No Abstract]   [Full Text] [Related]  

  • 52. Ouabain-induced inhibition of cardiac (Na+ plus K+)-ATPase and the positive inotropic response.
    Brody TM
    Ann N Y Acad Sci; 1974; 242(0):684-7. PubMed ID: 4279616
    [No Abstract]   [Full Text] [Related]  

  • 53. Purification (Na+ plus K+)-ATPase: active site determinations and criteria of purity.
    Jorgensen PL
    Ann N Y Acad Sci; 1974; 242(0):36-52. PubMed ID: 4279596
    [No Abstract]   [Full Text] [Related]  

  • 54. Direct evidence of sodium release in the course Na+, K+ -dependent ATPase reaction.
    Lev AA; Risareva LN
    Biochem Biophys Res Commun; 1970 Feb; 38(3):465-9. PubMed ID: 4246834
    [No Abstract]   [Full Text] [Related]  

  • 55. [Characterization of ouabain-binding conformation condition of (Na++ K+)-activated ATP-ase].
    Schön R; Schönfeld W; Repke KR
    Acta Biol Med Ger; 1970; 24(6):K61-5. PubMed ID: 4249240
    [No Abstract]   [Full Text] [Related]  

  • 56. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. 3. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of sodium, magnesium, and adenosine triphosphate.
    Yoda A; Yoda S
    Mol Pharmacol; 1974 May; 10(3):494-500. PubMed ID: 4277671
    [No Abstract]   [Full Text] [Related]  

  • 57. Diphenylhydantoin and Na-K-Mg activated adenosinetriphosphatase.
    Rawson MD; Pincus JH
    Neurology; 1968 Mar; 18(3):298. PubMed ID: 4231809
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiac glycosides: temporal relationship between the inotropic action and binding to and dissociation from Na+-K+-activated ATPase in vitro.
    Akera T; Baskin SI; Tobin T; Brody TM
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():149-54. PubMed ID: 4283208
    [No Abstract]   [Full Text] [Related]  

  • 59. Na, K-activated ATPase activity during and after arrhythmic response to AY-22-241 in the canine heart.
    Dutta S; Zavecz JH; Marks BH; Rhee HM; Brar S; Richards SR; Bhat HB
    Ann N Y Acad Sci; 1974; 242(0):671-82. PubMed ID: 4279614
    [No Abstract]   [Full Text] [Related]  

  • 60. A possible biochemical explanation for the insensitivity of the rat to cardiac glycosides.
    Allen JC; Schwartz A
    J Pharmacol Exp Ther; 1969 Jul; 168(1):42-6. PubMed ID: 4240031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.